Ogdol, Shane D.

HRN: 22-62-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
CEFUROXIME 750MG (VIAL)
05/08/2026
05/15/2026
IV
750mg
Q8
Uti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines